Status:
COMPLETED
Hemangioma Growth During the First 6 Months of Life
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Mayo Clinic
Medical College of Wisconsin
Conditions:
Hemangiomas of Infancy
Eligibility:
All Genders
3-5 years
Brief Summary
One of the most important and unique characteristics of infantile hemangiomas is their dramatic growth during early infancy. Most hemangiomas are either absent at birth or barely evident as a small sc...
Eligibility Criteria
Inclusion
- Children older than 3 months of age who have or have had a diagnosis of an infantile hemangioma. The parents of these children will be able to provide us with frequent (weekly to biweekly) photographs of the patient's hemangioma(s) during the first 3-6 months of life.
- These hemangiomas must have a superficial component that can be seen. Parents must consent to the use of their child's photographs in this study.
Exclusion
- Current age less than 3 months. Patient who do not have an infantile hemangioma (as determined by the investigators). Patients whose photographs are not of sufficient quality or frequency in order to be evaluated for this study.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00911781
Start Date
February 1 2009
End Date
December 1 2011
Last Update
February 5 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94115
2
Mayo Clinic
Rochester, Minnesota, United States, 55901